Added Therapeutic Value of New Drugs Approved in Brazil From 2004 to 2016

Cadernos de Saude Publica - Brazil
doi 10.1590/0102-311x00070018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

FapUNIFESP (SciELO)

Related search

Synthetic Approaches to New Drugs Approved During 2016

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2018English

Off-Label Use of Approved Drugs: Therapeutic Opportunity and Challenges

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2004English

New Minerals and Nomenclature Modifications Approved in 2016

Mineralogical Magazine
PetrologyGeochemistry
2016English

Identification of NUDT5 Inhibitors From Approved Drugs

Frontiers in Molecular Biosciences
BiochemistryGeneticsMolecular Biology
2020English

New Antimicrobial Agents Approved by the U.S. Food and Drug Administration in 2004 and New Indications for Previously Approved Agents

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Value Added

National Accounts at a Glance
2011English

Possible FDA-approved Drugs to Treat Ebola Virus Infection

Infectious Diseases of Poverty
MedicineEnvironmentalPublic HealthInfectious DiseasesOccupational Health
2015English

Clinical Trial of the Therapeutic Value of Certain Antirheumatic Drugs

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1960English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy